secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0000896622-25-000012
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup Q1 2025: sales down 3% to $887M, adjusted EPS $1.20, guides Q2 EPS $1.56-$1.64
--------------------------------------------------------------------------------

- Reported sales down 3% to $887M; net income down 5% to $79M; adjusted EPS $1.20 vs $1.22 prior year.
- Pharma core sales +3% on drug delivery systems; Beauty core -3% on lower fragrance; Closures core -2%.
- Adjusted EBITDA $183M (+3%); margin 20.7% (+120 bps) driven by pharma royalties.
- Q2 2025 adjusted EPS guidance $1.56-$1.64; effective tax rate 19%-21% vs 24% adjusted prior year.
- Repurchased 548k shares for $80M; quarterly dividend $0.45/share payable May 22, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000012/0000896622-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000012/atr-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000896622-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer